LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/LDR Rings Nasdaq Opening Bell!
Company News

LDR Rings Nasdaq Opening Bell!

December 3, 2014 1 min read Premium comments

Advertisement

LDR Rings Nasdaq Opening Bell!
Opening Bell / Courtesy: LDR Holding Corp.
Secondary

There were some extra special holiday bells ringing on December 2 for LDR Holding Corporation when the company—and specifically President and Chief Executive Officer Christophe Lavigne—had the honor of ringing the Nasdaq Stock Market Opening Bell. LDR is a medical device company focused on designing and commercializing novel and proprietary spinal surgical technologies.

The LDR team hit the Nasdaq MarketSite in Times Square, where Lavigne took the “stage” at 9:15 a.m. He told the world, “Good morning, thank you and merci! I am very happy for LDR to be part of the Nasdaq Exchange and to be here today. I, along with my two partners, founded LDR in France in 2000 with the goal to develop spine implant devices that would benefit patients suffering from debilitating spine conditions.”

“LDR technologies are designed to enable products that are less invasive, provide greater intra-operative flexibility, offer simplified surgical techniques and promote improved clinical outcomes for patients as compared to existing alternatives. We are very proud that one of our leading products, the Mobi-C Cervical Disc, is the only disc replacement device FDA approved for both one and two-level cervical disc replacement. I would like to personally thank my two partners, the LDR Executive Team who is with me here today, our employees around the world, our Management Board and also our Investors, who together have made today possible.”

Ring a ding…

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy